Product
Allogeneic Mesenchymal Bone Marrow Cells
1 clinical trial
2 indications
Indication
Photoaged SkinIndication
Skin DisordersClinical trial
A Phase I/II, Open-Label Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Allogeneic Mesenchymal Bone Marrow Cells to Subjects for Cutaneous PhotoagingStatus: Active (not recruiting), Estimated PCD: 2024-04-30